FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes heterocyclic nitrogen-containing derivatives of carboxylic acid or their salt of the formula (I) where R1 - hydrogen atom, group R3-(C= O)- and group R18S-; R2 and R19 - hydrogen atom, (C1-C7)-alkyl, group aryl-(CH2)m where aryl - phenyl or naphthalenyl; group heteroaryl-(CH2)n where heteroaryl - thienyl; n = 0 or 1; m = 0-6; R3 is (C1-C7)--alkyl, aryl-(CH2)m where aryl - phenyl; R18 is (C1-C7)-alkyl; X1 - a group of the formula (III) where R4 and R5 - hydrogen atom; R6 and R7 - hydrogen atom and others or X1 - a group of the formula (IV) where R6, R7, R8 and R9 - hydrogen atom or phenyl-(CH2)m- where m - as indicated above, S=O, r = 1 or X1/ - a group of the formula (V) or a group of the formula (VI) where Y1 - oxygen, sulfur atom or a group -CH2- and -CH2-CH2- or X1 - a group of the formula (VIII) or (IX) where Y2 - sulfur atom or a group -CH2- and ; v = 1 or 2; w = 1 or 2; or X1 - a group of the formula (XI) where Z - oxygen atom; v = 1 or 2, or X1/ - a group of the formula (XII) where Z - oxygen atom or two hydrogen atoms, or X1 - a group of the formula (XIII) where Y3 is -CH2-; R13 - hydrogen atom. Compounds of the formula (I) are synthesized by interaction of acylmercaptocarboxylic acid of the formula (XIV) with an intermediate compound of the formula (XV): H-X1 that results to formation of compound of the formula (XVI) followed by removal of acyl group R3-(C=O)- and ester protective group R12. Compounds of the formulas (XIV), (XV) and (XVI) are given in description of invention. Invention proposes also a pharmaceutical composition showing activity that inhibits angiotensin-converting enzyme and neural endopeptidase and contains compounds of the formula (I) and pharmaceutically acceptable carrier. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 8 cl
Authors
Dates
1999-01-10—Published
1993-05-17—Filed